Rheumatoid Arthritis (RA) Market Analysis

In 2017, the total prevalent cases of Rheumatoid Arthritis in 7MM was 4,356,793. The prevalent cases of Rheumatoid Arthritis in the United States were 1,333,290, while Germany had 836,101 prevalent cases in 2017.

The market size of Rheumatoid Arthritis in 7MM was USD 21.2 Billion in 2017.

Increase in the prevalence population of Rheumatoid Arthritis, increase in geriatric population and rich emerging pipeline are some of the key factors expected to drive the Rheumatoid Arthritis market in the coming years.

Some of the key players in the Rheumatoid Arthritis market include GlaxoSmithKline, Gilead, Galapagos NV, R-Pharm, Mesoblast, UCB Pharma/PRA HEALTH SCIENCES, Izana Bioscience/Takeda, Abivax S.A., Hope Biosciences and Genosco (Oscotec).

For more details, visit: https://www.delveinsight.com/report-store/rheumatoid-arthritis-ra-market